Recent Advances in the Detection of Glioblastoma, From Imaging-Based Methods to Proteomics and Biosensors: A Narrative Review

Recent Advances in the Detection of Glioblastoma, From Imaging-Based Methods to Proteomics and Biosensors: A Narrative Review Publisher

Hosseini A¹ ; Ashraf H² ; Rahimi F³ ; Alipourfard I⁴ ; Alivirdiloo V⁵ ; Hashemi B⁶ ; Yazdani Y⁷ ; Ghazi F⁸ ; Eslami M⁹ ; Ameri Shah Reza M¹⁰ ; Dadashpour M^{11, 12}

Show Affiliations

1. Razavi Cancer Research Center, Razavi Hospital, Mashhad, Iran
2. Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
3. Division of Clinical Laboratory, Zahra Mardani Azari Children Training, Research and Treatment Center, Tabriz University of Medical Sciences, Tabriz, Iran
4. Institute of Physical Chemistry, Polish Academy of Science, Warsaw, Poland
5. Mazandaran University of Medical Sciences, Medical Doctor Ramsar Campus, Ramsar, Iran
6. Department of Bacteriology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran
7. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
8. Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
9. Department of Medical Bacteriology and Virology, Semnan University of Medical Sciences, Semnan, Iran
10. Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran
11. Department of Medical Biotechnology, Semnan University of Medical Sciences, Semnan, Iran
12. Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran

Source: Cancer Cell International Published:2023

Abstract

Glioblastoma (GBM) is an aggressive type of cancer that originates in the cells called astrocytes, which support the functioning of nerve cells. It can develop in either the brain or the spinal cord and is also known as glioblastoma multiform. GBM is a highly aggressive cancer that can occur in either the brain or spinal cord. The detection of GBM in biofluids offers potential advantages over current methods for diagnosing and treatment monitoring of glial tumors. Biofluid-based detection of GBM focuses on identifying tumor-specific biomarkers in blood and cerebrospinal fluid. To date, different methods have been used to detect biomarkers of GBM, ranging from various imaging techniques to molecular approaches. Each method has its own strengths and weaknesses. The present review aims to scrutinize multiple diagnostic methods for GBM, with a focus on proteomics methods and biosensors. In other words, this study aims to provide an overview of the most significant research findings based on proteomics and biosensors for the diagnosis of GBM. © 2023, The Author(s).

Related Docs

View other Related Docs

1. A State-Of-The-Art Review on Solid Lipid Nanoparticles As a Nanovaccines Delivery System, Journal of Drug Delivery Science and Technology (2023)

2. Antimicrobial Effect of Chitosan–Silver–Copper Nanocomposite on Candida Albicans, Journal of Nanostructure in Chemistry (2020)

3. Microrna Biosensors for Detection of Glioblastoma, Clinica Chimica Acta (2024)

4. Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment, Cellular and Molecular Neurobiology (2023)

5. Exosomal Noncoding Rnas: Key Players in Glioblastoma Drug Resistance, Molecular and Cellular Biochemistry (2021)

6. How Do Phosphodiesterase-5 Inhibitors Affect Cancer? a Focus on Glioblastoma Multiforme, Pharmacological Reports (2022)

7. Therapeutic and Diagnostic Applications of Nanoparticles in the Management of Covid-19: A Comprehensive Overview, Virology Journal (2022)

8. Recent Advances in Treatment Crimean–Congo Hemorrhagic Fever Virus: A Concise Overview, Microbial Pathogenesis (2022)

Experts (# of related papers)

View all Related Experts

Mohsen Ghadami (1)

Seyed Jamal Hashemi Hezaveh (1)

Style	Citing Format
MLA	Hosseini A, et al.. "Recent Advances in the Detection of Glioblastoma, From Imaging-Based Methods to Proteomics and Biosensors: A Narrative Review." Cancer Cell International, vol. 23, no. 1, 2023, pp. -.
APA	Hosseini A, Ashraf H, Rahimi F, Alipourfard I, Alivirdiloo V, Hashemi B, Yazdani Y, Ghazi F, Eslami M, Ameri Shah Reza M, Dadashpour M (2023). Recent Advances in the Detection of Glioblastoma, From Imaging-Based Methods to Proteomics and Biosensors: A Narrative Review. Cancer Cell International, 23(1), -.
Chicago	Hosseini A, Ashraf H, Rahimi F, Alipourfard I, Alivirdiloo V, Hashemi B, Yazdani Y, et al.. "Recent Advances in the Detection of Glioblastoma, From Imaging-Based Methods to Proteomics and Biosensors: A Narrative Review." Cancer Cell International 23, no. 1 (2023): -.
Harvard	Hosseini A et al. (2023) 'Recent Advances in the Detection of Glioblastoma, From Imaging-Based Methods to Proteomics and Biosensors: A Narrative Review', Cancer Cell International, 23(1), pp. -.
Vancouver	Hosseini A, Ashraf H, Rahimi F, Alipourfard I, Alivirdiloo V, Hashemi B, et al.. Recent Advances in the Detection of Glioblastoma, From Imaging-Based Methods to Proteomics and Biosensors: A Narrative Review. Cancer Cell International. 2023;23(1):-.
BibTex	@article{ author = {Hosseini A and Ashraf H and Rahimi F and Alipourfard I and Alivirdiloo V and Hashemi B and Yazdani Y and Ghazi F and Eslami M and Ameri Shah Reza M and Dadashpour M}, title = {Recent Advances in the Detection of Glioblastoma, From Imaging-Based Methods to Proteomics and Biosensors: A Narrative Review}, journal = {Cancer Cell International}, volume = {23}, number = {1}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Hosseini A AU - Ashraf H AU - Rahimi F AU - Alipourfard I AU - Alivirdiloo V AU - Hashemi B AU - Yazdani Y AU - Ghazi F AU - Eslami M AU - Ameri Shah Reza M AU - Dadashpour M TI - Recent Advances in the Detection of Glioblastoma, From Imaging-Based Methods to Proteomics and Biosensors: A Narrative Review JO - Cancer Cell International VL - 23 IS - 1 SP - EP - PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract